Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Recce Pharmaceuticals Ltd. ( (AU:RCE) ) is now available.
Recce Pharmaceuticals Ltd announced the issuance of 4,634,304 unquoted warrants set to expire on July 30, 2030. This issuance is part of previously announced transactions and reflects the company’s ongoing efforts to strengthen its financial position, potentially enhancing its operational capabilities and market competitiveness.
The most recent analyst rating on (AU:RCE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Recce Pharmaceuticals Ltd. stock, see the AU:RCE Stock Forecast page.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd is a company in the pharmaceutical industry, focusing on the development and commercialization of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 149,109
Technical Sentiment Signal: Hold
Current Market Cap: A$120M
For an in-depth examination of RCE stock, go to TipRanks’ Overview page.